These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15196863)

  • 41. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
    Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
    J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y; Shen K; Tang PP
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):761-4. PubMed ID: 18307904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-tumor effect of lentivirus-mediated MUCI antibody-targeted gene therapy with VP22-TK system on MUC1(+) human ovarian cancer transplanted intraperitoneally in nude mice].
    Kong B; Wang W; Liu C; Ma D; Qu X; Jiang J; Yang X; Zhang Y; Jiang S
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(17):1207-10. PubMed ID: 12475412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epigenetics changes caused by the fusion of human embryonic stem cell and ovarian cancer cells.
    He K; Qu H; Xu LN; Gao J; Cheng FY; Xiang P; Zhou CQ
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27377320
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interference of Ca²⁺ with the proliferation of SCCOHT-1 and ovarian adenocarcinoma cells.
    Otte A; Rauprich F; von der Ohe J; Hillemanns P; Hass R
    Int J Oncol; 2014 Sep; 45(3):1151-8. PubMed ID: 24969518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficient inhibition of an intraperitoneal xenograft model of human ovarian cancer by HSulf-1 gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels.
    Liu P; Gou M; Yi T; Xie C; Qi X; Zhou S; Deng H; Wei Y; Zhao X
    Oncol Rep; 2012 Feb; 27(2):363-70. PubMed ID: 22086394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor and normal cell protective effect of PKC412 in the athymic mouse model of ovarian cancer.
    Kim M; Park IY; Lim J; Kim Y; Han KT; Chung WH; Han K
    Ann Clin Lab Sci; 2006; 36(4):455-60. PubMed ID: 17127735
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Akt inhibitor enhances apoptotic effect of carboplatin on human epithelial ovarian carcinoma cell lines.
    Lee CS; Kim YJ; Jang ER; Myung SC; Kim W
    Eur J Pharmacol; 2010 Apr; 632(1-3):7-13. PubMed ID: 20096282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen.
    Nitta M; Katabuchi H; Ohtake H; Tashiro H; Yamaizumi M; Okamura H
    Gynecol Oncol; 2001 Apr; 81(1):10-7. PubMed ID: 11277643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene].
    Guo MG; Jiang MH; Yang Q; Li YM; Cui ZF; Li LF; Wu MC; Qian QJ
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1147-51. PubMed ID: 15387973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin.
    van den Brûle F; Califice S; Garnier F; Fernandez PL; Berchuck A; Castronovo V
    Lab Invest; 2003 Mar; 83(3):377-86. PubMed ID: 12649338
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro analysis of the anticancer potential of tumor necrosis factor in combination with cisplatin.
    Mutch DG; Powell CB; Kao MS; Collins JL
    Gynecol Oncol; 1989 Sep; 34(3):328-33. PubMed ID: 2767524
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted optical fluorescence imaging of human ovarian adenocarcinoma using a galactosyl serum albumin-conjugated fluorophore.
    Gunn AJ; Hama Y; Koyama Y; Kohn EC; Choyke PL; Kobayashi H
    Cancer Sci; 2007 Nov; 98(11):1727-33. PubMed ID: 17784874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic variations and differential migration of NIH:OVCAR-3 ovarian carcinoma cells isolated from athymic mice.
    Veatch AL; Carson LF; Ramakrishnan S
    Clin Exp Metastasis; 1995 May; 13(3):165-72. PubMed ID: 7750204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stably Fluorescent Cell Line of Human Ovarian Epithelial Cancer Cells SK-OV-3ip-red.
    Konovalova EV; Shulga AA; Chumakov SP; Khodarovich YM; Woo EJ; Deev SM
    Bull Exp Biol Med; 2017 Nov; 164(1):99-101. PubMed ID: 29124539
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumorigenicity and Validity of Fluorescence Labelled Mesenchymal and Epithelial Human Oral Cancer Cell Lines in Nude Mice.
    Cai WX; Zheng LW; Ma L; Huang HZ; Yu RQ; Zwahlen RA
    Biomed Res Int; 2016; 2016():4897986. PubMed ID: 27957498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytotoxic activity of genistein-8-C-glucoside form
    Antosiak A; Milowska K; Maczynska K; Rozalska S; Gabryelak T
    Med Chem Res; 2017; 26(1):64-73. PubMed ID: 28111515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo horizontal oncogenesis by a human tumor in nude mice.
    Goldenberg DM; Pavia RA
    Proc Natl Acad Sci U S A; 1982 Apr; 79(7):2389-92. PubMed ID: 6954547
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of dimethylsulfoxide as a vehicle in cell culture experiments using ovarian carcinoma cell lines.
    Rodríguez-Burford C; Oelschlager DK; Talley LI; Barnes MN; Partridge EE; Grizzle WE
    Biotech Histochem; 2003 Feb; 78(1):17-21. PubMed ID: 12713137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells.
    Melzer C; von der Ohe J; Hass R
    Cell Commun Signal; 2018 Oct; 16(1):67. PubMed ID: 30316300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.